Signalling via integrins: implications for cell survival and anticancer strategies

S Hehlgans, M Haase, N Cordes - … et Biophysica Acta (BBA)-Reviews on …, 2007 - Elsevier
Integrin-associated signalling renders cells more resistant to genotoxic anti-cancer agents
like ionizing radiation and chemotherapeutic substances, a phenomenon termed cell …

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

A Gras Navarro, AT Björklund, M Chekenya - Frontiers in immunology, 2015 - frontiersin.org
Natural killer (NK) cells are innate lymphoid cells that hold tremendous potential for effective
immunotherapy for a broad range of cancers. Due to the mode of NK cell killing, requiring …

[PDF][PDF] Cancer statistics, 2006

A Jemal, R Siegel, E Ward, T Murray, J Xu, C Smigal… - CA-ATLANTA-, 2006 - academia.edu
ABSTRACT Each year, the American Cancer Society estimates the number of new cancer
cases and deaths expected in the United States in the current year and compiles the most …

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

T Crosby, CN Hurt, S Falk, S Gollins… - The lancet …, 2013 - thelancet.com
Background Definitive chemoradiotherapy (CRT) is an alternative to surgery for the curative
treatment of oesophageal carcinoma. The SCOPE1 trial aimed to investigate the addition of …

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.

J Harding, B Burtness - Drugs of today (Barcelona, Spain: 1998), 2005 - europepmc.org
The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptors. It
is composed of extracellular domains, including a ligand-binding domain, a hydrophobic …

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

RM Sharkey, DM Goldenberg - CA: a cancer journal for …, 2006 - Wiley Online Library
ABSTRACT Immunotherapy of cancer has been explored for over a century, but it is only in
the last decade that various antibody‐based products have been introduced into the …

Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity

K Dittmann, C Mayer, HP Rodemann - Radiotherapy and Oncology, 2005 - Elsevier
BACKGROUND AND PURPOSE: Inhibition of EGFR-function can induce radiosensitization
in tumor cells. Purpose of our investigation was to identify the possible molecular …

Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents

DA Reardon, PY Wen - The oncologist, 2006 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe the
genetic alterations frequently observed in GBM tumors as well as the cell signal transduction …

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications

M Zimmermann, A Zouhair, D Azria, M Ozsahin - Radiation oncology, 2006 - Springer
Epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptors. Its
stimulation by endogenous ligands, EGF or transforming growth factor-alpha (TGF-α) results …

Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by …

M Toulany, U Kasten-Pisula, I Brammer, S Wang… - Clinical Cancer …, 2006 - AACR
Purpose: It is known that blockage of epidermal growth factor receptor (EGFR)/
phosphatidylinositol 3-kinase (PI3K) activity enhances radiation sensitivity of human tumor …